Minimal stimulation IVF with late follicular phase administration of the GnRH antagonist cetrorelix and concomitant substitution with recombinant FSH: a pilot study
Author(s) -
M.J. Pelinck,
N.E.A. Vogel,
Annemieke Hoek,
Jos Arts,
Arnold Simons,
MJ Heineman
Publication year - 2004
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/deh685
Subject(s) - embryo transfer , follicular phase , pregnancy , pregnancy rate , live birth , medicine , controlled ovarian hyperstimulation , ovarian hyperstimulation syndrome , gynecology , ovulation induction , hormone antagonist , obstetrics , in vitro fertilisation , antagonist , biology , hormone , ovulation , genetics , receptor
The use of the natural cycle for IVF offers the advantage of a patient-friendly and low-risk protocol. Its effectiveness is limited, but may be improved by using a GnRH antagonist to prevent untimely LH surges.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom